Emma K Genco1, Jeri E Forster2, Hanna Flaten3, Foster Goss3, Kennon J Heard3, Jason Hoppe3, Andrew A Monte3. 1. Department of Emergency Medicine, University of Colorado School of Medicine, Denver, CO. Electronic address: emma.genco@ucdenver.edu. 2. Department of Physical Medicine and Rehabilitation, University of Colorado School of Medicine, Denver, CO; VA VISN 19 Rocky Mountain Mental Illness Research, Education, and Clinical Center (MIRECC), Denver, CO. 3. Department of Emergency Medicine, University of Colorado School of Medicine, Denver, CO.
Abstract
STUDY OBJECTIVE: We examine the characteristics of clinical decision support alerts triggered when opioids are prescribed, including alert type, override rates, adverse drug events associated with opioids, and preventable adverse drug events. METHODS: This was a retrospective chart review study assessing adverse drug event occurrences for emergency department (ED) visits in a large urban academic medical center using a commercial electronic health record system with clinical decision support. Participants include those aged 18 to 89 years who arrived to the ED every fifth day between September 2012 and January 2013. The main outcome was characteristics of opioid drug alerts, including alert type, override rates, opioid-related adverse drug events, and adverse drug event preventability by clinical decision support. RESULTS: Opioid drug alerts were more likely to be overridden than nonopioid alerts (relative risk 1.35; 95% confidence interval [CI] 1.21 to 1.50). Opioid drug-allergy alerts were twice as likely to be overridden (relative risk 2.24; 95% CI 1.74 to 2.89). Opioid duplicate therapy alerts were 1.57 times as likely to be overridden (95% CI 1.30 to 1.89). Fourteen of 4,581 patients experienced an adverse drug event (0.31%; 95% CI 0.15% to 0.47%), and 8 were due to opioids (57.1%). None of the adverse drug events were preventable by clinical decision support. However, 46 alerts were accepted for 38 patients that averted a potential adverse drug event. Overall, 98.9% of opioid alerts did not result in an actual or averted adverse drug event, and 96.3% of opioid alerts were overridden. CONCLUSION: Overridden opioid alerts did not result in adverse drug events. Clinical decision support successfully prevented adverse drug events at the expense of generating a large volume of inconsequential alerts. To prevent 1 adverse drug event, providers dealt with more than 123 unnecessary alerts. It is essential to refine clinical decision support alerting systems to eliminate inconsequential alerts to prevent alert fatigue and maintain patient safety.
STUDY OBJECTIVE: We examine the characteristics of clinical decision support alerts triggered when opioids are prescribed, including alert type, override rates, adverse drug events associated with opioids, and preventable adverse drug events. METHODS: This was a retrospective chart review study assessing adverse drug event occurrences for emergency department (ED) visits in a large urban academic medical center using a commercial electronic health record system with clinical decision support. Participants include those aged 18 to 89 years who arrived to the ED every fifth day between September 2012 and January 2013. The main outcome was characteristics of opioid drug alerts, including alert type, override rates, opioid-related adverse drug events, and adverse drug event preventability by clinical decision support. RESULTS: Opioid drug alerts were more likely to be overridden than nonopioid alerts (relative risk 1.35; 95% confidence interval [CI] 1.21 to 1.50). Opioid drug-allergy alerts were twice as likely to be overridden (relative risk 2.24; 95% CI 1.74 to 2.89). Opioid duplicate therapy alerts were 1.57 times as likely to be overridden (95% CI 1.30 to 1.89). Fourteen of 4,581 patients experienced an adverse drug event (0.31%; 95% CI 0.15% to 0.47%), and 8 were due to opioids (57.1%). None of the adverse drug events were preventable by clinical decision support. However, 46 alerts were accepted for 38 patients that averted a potential adverse drug event. Overall, 98.9% of opioid alerts did not result in an actual or averted adverse drug event, and 96.3% of opioid alerts were overridden. CONCLUSION: Overridden opioid alerts did not result in adverse drug events. Clinical decision support successfully prevented adverse drug events at the expense of generating a large volume of inconsequential alerts. To prevent 1 adverse drug event, providers dealt with more than 123 unnecessary alerts. It is essential to refine clinical decision support alerting systems to eliminate inconsequential alerts to prevent alert fatigue and maintain patient safety.
Authors: Nidhi R Shah; Andrew C Seger; Diane L Seger; Julie M Fiskio; Gilad J Kuperman; Barry Blumenfeld; Elaine G Recklet; David W Bates; Tejal K Gandhi Journal: J Am Med Inform Assoc Date: 2005-10-12 Impact factor: 4.497
Authors: Nidhi R Shah; Andrew C Seger; Diane L Seger; Julie M Fiskio; Gilad J Kuperman; Barry Blumenfeld; Elaine G Recklet; David W Bates; Tejal K Gandhi Journal: AMIA Annu Symp Proc Date: 2005
Authors: Daniel S Budnitz; Daniel A Pollock; Kelly N Weidenbach; Aaron B Mendelsohn; Thomas J Schroeder; Joseph L Annest Journal: JAMA Date: 2006-10-18 Impact factor: 56.272
Authors: Marilyn D Paterno; Saverio M Maviglia; Paul N Gorman; Diane L Seger; Eileen Yoshida; Andrew C Seger; David W Bates; Tejal K Gandhi Journal: J Am Med Inform Assoc Date: 2008-10-24 Impact factor: 4.497
Authors: Tyken C Hsieh; Gilad J Kuperman; Tonushree Jaggi; Patricia Hojnowski-Diaz; Julie Fiskio; Deborah H Williams; David W Bates; Tejal K Gandhi Journal: J Am Med Inform Assoc Date: 2004-08-06 Impact factor: 4.497
Authors: Laura Barrie Smith; Ezra Golberstein; Kelly Anderson; Tori Christiaansen; Nicole Paterson; Sonja Short; Hannah T Neprash Journal: J Gen Intern Med Date: 2019-08 Impact factor: 5.128
Authors: Foster R Goss; Kenneth H Lai; Maxim Topaz; Warren W Acker; Leigh Kowalski; Joseph M Plasek; Kimberly G Blumenthal; Diane L Seger; Sarah P Slight; Kin Wah Fung; Frank Y Chang; David W Bates; Li Zhou Journal: J Am Med Inform Assoc Date: 2018-06-01 Impact factor: 4.497
Authors: Howard S Kim; Danielle M McCarthy; Jason A Hoppe; D Mark Courtney; Bruce L Lambert Journal: Acad Emerg Med Date: 2017-09-19 Impact factor: 3.451
Authors: Maxim Topaz; Foster Goss; Kimberly Blumenthal; Kenneth Lai; Diane L Seger; Sarah P Slight; Paige G Wickner; George A Robinson; Kin Wah Fung; Robert C McClure; Shelly Spiro; Warren W Acker; David W Bates; Li Zhou Journal: Int J Med Inform Date: 2016-10-06 Impact factor: 4.046
Authors: Dustin W Ballard; Ridhima Vemula; Uli K Chettipally; Mamata V Kene; Dustin G Mark; Andrew K Elms; James S Lin; Mary E Reed; Jie Huang; Adina S Rauchwerger; David R Vinson Journal: Appl Clin Inform Date: 2016-09-21 Impact factor: 2.342